Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

All Stories

Asset management study: 5 things OMGI told the FCA

Old Mutual Global Investors reveals its five recommendations to the watchdog's competition study.

Brooks Macdonald partners with online adviser forum

Brooks Macdonald will provide videos and education guides for financial advisers and paraplanners on Panacea Adviser.

SJP swoops on Dorking-based advice firm

SJP has bought HJP Independent Financial Advisers, which was founded in 1990 and has 10 advisers with CF30 customer function and four directors on its books.

Investec's Hutchins applauds Unilever's Kraft rejection

Although Unilever's shares have been on a 'rollercoaster ride', Investec's Blake Hutchins welcomes the rejection of Kraft Heinz's bid.

Brewin Dolphin wins battle for NHS charity mandate

The firm has been appointed investment manager for the Velindre NHS Charitable Trust fund after a ‘competitive tendering process'.

Rathbones, Brooks and LGT Vestra sign up with tech firm

Rathbones, LGT Vestra and Brooks Macdonald all agree to use wealth tech firm WDX's software

RBS tops FTSE as Williams & Glyn sale shelved

RBS jumps to top of FTSE 100, offsetting Unilever's slide, as investors welcome plans to shelve sale of Williams & Glyn branches.

Vanguard calls for 'health warnings' on pricey funds

Vanguard calls for fee warning to be given the same weight as past performance in ‘radically simpler’ communications makeover

Waverton hires fund selection boss from John Duffield's firm

Luke Hyde-Smith joins in newly-created role from Brompton Asset Management.

Unilever slides as Kraft Heinz abandons $143bn bid

Shares in Unilever have tumbled as a hostile response spooks Kraft into pulling support for $50 a share bid.

Investment Trust video
Play James Henderson's HOT trades post-Brexit

James Henderson's HOT trades post-Brexit

James Henderson, the manager of the Henderson Opportunities Trust has been finding opportunities to invest since the summer, especially in the pharmaceuticals sector.